The US investigates Germany under Section 301 of the Trade Act of 1974, alleging its drug price regulation system forces US patients and businesses to pay disproportionately higher prices for pharmaceutical R&D, potentially leading to new tariffs.
José Manuel Durão Barroso, Chair di Gavi, sottolinea a WOMA 2026 la necessità di collaborazione internazionale per affrontare le sfide della salute globale, minacciate dalla crescente frammentazione geopolitica.
States are enacting laws to regulate Pharmacy Benefit Managers (PBMs) due to concerns over high drug costs. These PBMs, like CVS, manage prescription coverage and negotiate drug prices. Regulations aim to limit PBM compensation, set minimum pharmacist payments, and increase transparency, facing opposition and legal challenges from companies like CVS.
States are enacting laws to regulate pharmacy benefit managers (PBMs) due to rising drug costs. These PBMs, which manage prescription coverage for insurers, are facing restrictions on their operations and compensation. CVS Health is actively fighting these regulations through lawsuits and advertising campaigns, while independent pharmacies argue they are being squeezed by PBMs' practices.
La Commission européenne a lancé une enquête formelle contre le géant pharmaceutique français Sanofi, soupçonné d'abus de position dominante sur le marché des vaccins antigrippaux. Sanofi est accusé d'avoir dénigré le vaccin Fluad de CSL Seqirus, concurrent de son Efluelda, notamment en Allemagne et en France.
La Commission européenne a ouvert une enquête formelle contre Sanofi, soupçonné d'avoir dénigré un vaccin concurrent pour favoriser son propre produit. La campagne visait des professionnels de santé en France et en Allemagne.
CEE Kerala released the KEAM 2026 rank list today, June 26, for over 1.48 lakh candidates. The publication was delayed to allow Class 12 marks updates after CBSE revaluation. The centralized allotment process will commence late June/July.
Bayer hat vor dem Obersten Gericht der USA einen wichtigen Erfolg in den Glyphosat-Rechtsstreitigkeiten erzielt. Das Urteil besagt, dass Klagen wegen fehlender Krebswarnungen auf Roundup-Verpackungen unzulässig sind, da die EPA die Kennzeichnung genehmigte. Die Bayer-Aktie stieg daraufhin um über 18 Prozent.
Der Pharma- und Technologiekonzern Merck aus Darmstadt erwirbt den US-Laborausrüster Bio-Techne für 11,3 Milliarden Dollar (9,9 Milliarden Euro). Die Übernahme ist der erste große Deal unter dem neuen Vorstandschef Kai Beckmann und stärkt das Life-Science-Geschäft.
Goldman Sachs predicts China's rapid aging will boost pharmaceutical and biotech sectors, citing companies like Zai Lab and WuXi XDC Cayman. Conversely, carmakers and tech hardware manufacturers may face challenges due to demographic shifts.
Ukrainian pharmaceutical companies are reportedly exiting the country due to a severe shortage of specialists and labor. Biopharma plans to open an €85 million production facility in Romania by late 2027.
Investor Sandip Sabharwal warns defence stock prices have outpaced reality, favoring Bharat Electronics but calling small-cap defence stocks "obnoxious." He sees decent but unexciting prospects in pharma, constructive growth in private banks, and attractive but trigger-lacking IT valuations. Bharat Forge is a manufacturing standout, though some power equipment firms are overvalued.
Der US-Pharmakonzern Abbvie übernimmt das Biotechunternehmen Apogee Therapeutics für 10,9 Milliarden Dollar, um seine Medikamenten-Pipeline zu stärken. Die Übernahme sichert Zugang zu vielversprechenden Wirkstoffen, darunter ein Mittel gegen Neurodermitis, das eine Konkurrenz zu Dupixent darstellen könnte.
Aurobindo Pharma's US subsidiary has received FTC approval for its $250 million acquisition of Lannett Company. The deal, expected to close by June 2026, will enhance Aurobindo's complex generics and controlled substances portfolio and boost US manufacturing.
Europäische KI-Start-ups wie Mistral und Elevenlabs ziehen Milliardeninvestitionen an und werden zu Decacorns. Investoren und Konzerne sehen darin Europas zweite Chance im globalen KI-Wettbewerb, insbesondere in Bereichen wie Labore, Fahrzeuge und Fabriken.
Casos de lesão hepática foram registrados em Victoria, Austrália, após o uso de produtos com retatrutida, substância para obesidade e diabetes. Autoridades suspeitam de contaminantes em versões ilegais comercializadas online.
Merz Pharma investiert über 100 Mio. Euro bis 2028 in den Standort Dessau-Roßlau, um Produktions-, Verpackungs- und Logistikkapazitäten auszubauen. CEO Philip Burchard bekräftigt das Vertrauen in den Industriestandort Deutschland angesichts gestiegener Nachfrage nach Neurotoxinen.
The US has initiated a Section 301 trade investigation into Germany's pharmaceutical pricing policies, alleging they unfairly burden US commerce and force the US to fund a disproportionate share of global drug R&D, potentially leading to new tariffs.
CVS is transitioning its over-the-counter medications to aluminum bottles, moving away from traditional plastic packaging. This change aims to improve sustainability and product stability, with initial conversions focusing on value-sized allergy and pain medications.
The U.S. has launched an investigation into Germany's pharma policies, citing "persistent underpayment" for medicines as Germany seeks to control rising healthcare costs. U.S. Trade Representative Jamieson Greer expressed concern over proposed legislation to reduce drug spending, calling it a "serious step backwards."
Die USA prüfen Deutschlands Pharmapolitik und drohen mit Zöllen. Grund: Die US-Regierung wirft Deutschland vor, durch niedrige Arzneimittelpreise die weltweiten Forschungs- und Entwicklungskosten unverhältnismäßig auf amerikanische Patienten abzuwälzen.
Zealand Pharma's stock dropped significantly due to high dropout rates for its weight loss drug survodutide. While survodutide's peak sales forecasts were cut, investors are now focusing on the company's amylin-based drug, petrelintide, as a potential future growth driver.
Zealand Pharma's stock dropped significantly due to high dropout rates for its weight loss drug survodutide. Investors are now focusing on its amylin-based drug, petrelintide, as the next potential growth driver, despite competition and previous efficacy concerns.
Die USA haben eine Handelsuntersuchung gegen Deutschland wegen der Preisgestaltung für Medikamente eingeleitet. Geprüft wird, ob Deutschland für innovative Pharmaprodukte zu wenig bezahlt.
